8-(4-CHLOROPHENYL)-8-(2-METHYLROPOXY)-5-METHYL-8H-[1,4]-THIAZINO-[3,4-C]-[1,2,4]-OXADIAZOL-3-ONE
Compound with spectra: 1 NMR
![8-(4-CHLOROPHENYL)-8-(2-METHYLROPOXY)-5-METHYL-8H-[1,4]-THIAZINO-[3,4-C]-[1,2,4]-OXADIAZOL-3-ONE](/api/compound/F32wtsiOVz.png?ph=true&h=300&w=458 "8-(4-CHLOROPHENYL)-8-(2-METHYLROPOXY)-5-METHYL-8H-[1,4]-THIAZINO-[3,4-C]-[1,2,4]-OXADIAZOL-3-ONE")
| SpectraBase Compound ID | F32wtsiOVz |
|---|---|
| InChI | InChI=1S/C16H17ClN2O3S/c1-10(2)8-21-16(12-4-6-13(17)7-5-12)14-18-22-15(20)19(14)11(3)9-23-16/h4-7,9-10H,8H2,1-3H3 |
| InChIKey | NUKJMDCJFLMBDA-UHFFFAOYSA-N |
| Mol Weight | 352.84 g/mol |
| Molecular Formula | C16H17ClN2O3S |
| Exact Mass | 352.064841 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
8-(4-Fluorophenyl)-8-ethoxy-8H-[1,4]thiazino[3,4-c][1,2,4]oxadiazol-3-one
8-(4-Bromophenyl)-8-[(2Z)-hex-2-en-1-yloxy]-5-methyl-8H-[1,2,4]oxadiazolo[3,4-c][1,4]thiazin-3-one
(3-benzoyl-1,5-diphenyl-4-pyrazolyl)-phenylmethanone
EGC-3'-GLUC;(-)-EPIGALLOCATECHIN-3'-GLUCURONATE
3-Methyl-2-phenyl-2H-pyrazino[2,1-b]quinazoline-1,6-dione
1-(4-hydroxyphenyl)-7,7-dimethyl-4-(4-nitrophenyl)-3,4,6,8-tetrahydroquinoline-2,5-dione
3,8,9-Trichloro-1-(3-chloropropyl)-1,10-phenanthrolin-2(1H)-one
4-Phenyl-2-oxa-3-aza-R-1,C-5,C-6,C-7,T-8,T-11,C-12,C-13-pentacyclo(80)pentadeca-3,9-diene.3.1/8,11/.1/6,13/.0/7,12/.
5,6,7,8-Tetrahydro-1-(2-methylnaphthalen-1-yl)-3-phenylisoquinoline
3-pyridinecarboxylic acid, 5-cyano-6-[[2-[(2,6-dimethylphenyl)amino]-2-oxoethyl]thio]-1,4-dihydro-2-methyl-4-(2-thienyl)-, 2-propenyl ester
| Title | Journal or Book | Year |
|---|---|---|
| Cardiovascular Characterization of [1,4]Thiazino[3,4-c][1,2,4]oxadiazol-1-one Derivatives: Selective Myocardial Calcium Channel Modulators | Journal of Medicinal Chemistry | 2002 |